Best of ASCO Presentations

Initial reporting of NRG-LU001, randomized phase II trial of concurrent chemoradiotherapy +/- metformin in locally advanced non-small cell lung cancer


Presenter:  Theodoros Tsakiridis, MD, McMaster University


Date and Time: Saturday, June 1, 2019, 1:39-1:51pm

 

Location: Lakeside, L3, Hall D2

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer — First experimental arm initial results


Presenter:  Thomas George, MD, FACP, UF Health


Date and Time: Saturday, June 1, 2019, 4:24-4:36pm

 

Location: North Building, L3, Hall B1

Impact of clinical risk category on prognosis and prediction of
chemotherapy benefit in early breast cancer by age and the 21-gene recurrence score in TAILORx


Presenter:  Joseph A. Sparano, MD, Albert Einstein College of Medicine


Date and Time: Monday, June 3, 2019, 10:45-10:57am

 

Location: Lakeside, L3, Hall D2

Patient-reported outcomes in NRG oncology/NSABP B-39/ RTOG 0413: A randomized phase III study of conventional whole breast irradiation versus partial breast irradiation in stage 0, I, or II breast cancer


Presenter:  Patricia Ganz, MD, UCLA


Date and Time: Monday, June 3, 2019, 12:09-12:21pm

 

Location: Lakeside, L3, Hall D2

A randomized phase 3 trial of paclitaxel plus carboplatin versus paclitaxel plus ifosfamide in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial


Presenter:  Matthew A. Powell, MD, Washington University School of Medicine


Date and Time: Monday, June 3, 2019, 1:15-1:27pm

 

Location: South Building, L4, S406

Updated predictive analysis of the WHO-defined molecular subgroups of low-grade gliomas within the high-risk treatment arms of NRG Oncology/RTOG 9802


Presenter:  Erica H. Bell, PhD, The Ohio State University


Date and Time: Monday, June 3, 2019, 2:03-2:15pm

 

Location: South Building, L3, Hall A

Award Presentations

Dr. Wolmark to receive the prestigious Gianni Bonadonna Breast Cancer Award at ASCO's 2019 Annual Meeting
Norman Wolmark, MD, an NRG Oncology Group Chair and Chairman of the NSABP Foundation, will receive the 2019 Gianni Bonadonna Breast Cancer Award at the ASCO Annual Meeting. As a recipient of this award, Dr. Wolmark will deliver his address, "The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer: A 60-year Odyssey" on Saturday, June 1, 2019 (4:45-5:30pm CT). 

The Gianni Bonadonna Breast Cancer Lecture Award recognizes an active clinical researcher with a distinguished record of accomplishments in advancing breast cancer research. For more information about the award and past recipients, click  here.

Dr. Wolmark's Address:
 "The Contribution of NSABP Clinical Trials to the Management of Early Breast Cancer: A 60-year Odyssey"


Date and Time: Saturday, June 1, 2019, 4:45-5:30pm

 

Location: Lakeside, L3, Hall D1

All NRG Oncology ASCO 2019 Presentations

The full schedule of NRG Oncology presentations at ASCO can be found on our website.

Connect with us!
Engage with NRG Oncology

We will be posting about ASCO on our social media! Be sure to follow us at NRG Oncology on Facebook or @NRGOnc on Twitter and Instagram. Use our hashtag #NRGatASCO19 to be a part of the conversation. 
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse